 Leigh Bakel
Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Pathways | 7 | 2025 | 109 | 2.040 |
Why?
| | Hospitals, Pediatric | 8 | 2024 | 558 | 1.810 |
Why?
| | Bronchiolitis | 4 | 2024 | 87 | 1.470 |
Why?
| | Gastroenteritis | 1 | 2022 | 63 | 0.680 |
Why?
| | Asthma | 4 | 2022 | 1797 | 0.640 |
Why?
| | Electronic Health Records | 4 | 2026 | 1202 | 0.560 |
Why?
| | Internationality | 1 | 2017 | 156 | 0.500 |
Why?
| | Quality Improvement | 5 | 2025 | 1296 | 0.460 |
Why?
| | Medical Records, Problem-Oriented | 1 | 2014 | 6 | 0.420 |
Why?
| | Medical Staff, Hospital | 1 | 2014 | 80 | 0.400 |
Why?
| | Databases, Factual | 1 | 2017 | 1491 | 0.340 |
Why?
| | Patient Discharge | 2 | 2014 | 995 | 0.320 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1582 | 0.320 |
Why?
| | Anti-Bacterial Agents | 3 | 2026 | 1925 | 0.300 |
Why?
| | Length of Stay | 3 | 2025 | 1350 | 0.290 |
Why?
| | Hospitalization | 4 | 2024 | 2460 | 0.260 |
Why?
| | Child | 13 | 2026 | 22739 | 0.240 |
Why?
| | Advisory Committees | 2 | 2020 | 229 | 0.240 |
Why?
| | Physicians | 1 | 2014 | 956 | 0.230 |
Why?
| | Amoxicillin | 1 | 2025 | 35 | 0.220 |
Why?
| | Professional Practice | 1 | 2025 | 57 | 0.220 |
Why?
| | Croup | 1 | 2024 | 19 | 0.210 |
Why?
| | Hospital Costs | 1 | 2025 | 125 | 0.210 |
Why?
| | Internship and Residency | 1 | 2014 | 1269 | 0.200 |
Why?
| | Practice Patterns, Physicians' | 4 | 2026 | 1372 | 0.200 |
Why?
| | Community-Acquired Infections | 1 | 2025 | 177 | 0.190 |
Why?
| | Otitis Media | 1 | 2026 | 182 | 0.190 |
Why?
| | Analgesics, Opioid | 2 | 2021 | 1154 | 0.190 |
Why?
| | Emergency Service, Hospital | 5 | 2026 | 2383 | 0.170 |
Why?
| | Decision Support Systems, Clinical | 1 | 2026 | 273 | 0.170 |
Why?
| | Infant | 8 | 2026 | 10090 | 0.170 |
Why?
| | Retrospective Studies | 9 | 2026 | 17325 | 0.170 |
Why?
| | Acute Pain | 1 | 2021 | 58 | 0.160 |
Why?
| | Humans | 21 | 2026 | 145763 | 0.150 |
Why?
| | Pneumonia | 1 | 2025 | 636 | 0.150 |
Why?
| | Child, Preschool | 7 | 2026 | 11868 | 0.150 |
Why?
| | Ambulatory Care | 4 | 2026 | 610 | 0.140 |
Why?
| | Bacterial Infections | 1 | 2021 | 246 | 0.140 |
Why?
| | Medical Overuse | 1 | 2018 | 30 | 0.130 |
Why?
| | Inpatients | 1 | 2022 | 553 | 0.130 |
Why?
| | Referral and Consultation | 1 | 2023 | 868 | 0.120 |
Why?
| | Pediatrics | 2 | 2015 | 1125 | 0.120 |
Why?
| | Fractures, Bone | 1 | 2021 | 428 | 0.120 |
Why?
| | Respiratory Sounds | 1 | 2016 | 103 | 0.110 |
Why?
| | Infant, Newborn | 3 | 2023 | 6464 | 0.110 |
Why?
| | Sepsis | 1 | 2021 | 664 | 0.110 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 5922 | 0.110 |
Why?
| | Secondary Prevention | 1 | 2016 | 251 | 0.110 |
Why?
| | Meaningful Use | 1 | 2014 | 13 | 0.100 |
Why?
| | Anti-Asthmatic Agents | 1 | 2016 | 260 | 0.100 |
Why?
| | Adolescent | 6 | 2026 | 22573 | 0.100 |
Why?
| | Delivery of Health Care | 2 | 2023 | 947 | 0.090 |
Why?
| | Hemolytic-Uremic Syndrome | 1 | 2012 | 15 | 0.090 |
Why?
| | Ticlopidine | 1 | 2012 | 52 | 0.090 |
Why?
| | Psychiatry | 1 | 2014 | 195 | 0.080 |
Why?
| | Diarrhea | 1 | 2012 | 193 | 0.080 |
Why?
| | United States | 3 | 2024 | 16123 | 0.080 |
Why?
| | Respiratory Tract Infections | 1 | 2015 | 396 | 0.080 |
Why?
| | Pilot Projects | 1 | 2014 | 1897 | 0.070 |
Why?
| | Patient Readmission | 2 | 2024 | 772 | 0.060 |
Why?
| | Controlled Before-After Studies | 1 | 2025 | 15 | 0.060 |
Why?
| | Non-Randomized Controlled Trials as Topic | 1 | 2025 | 20 | 0.060 |
Why?
| | Interrupted Time Series Analysis | 1 | 2025 | 75 | 0.050 |
Why?
| | Male | 7 | 2026 | 73003 | 0.050 |
Why?
| | Azithromycin | 1 | 2025 | 101 | 0.050 |
Why?
| | Bias | 1 | 2025 | 197 | 0.050 |
Why?
| | Antimicrobial Stewardship | 1 | 2026 | 130 | 0.050 |
Why?
| | Ambulatory Care Facilities | 1 | 2026 | 269 | 0.050 |
Why?
| | Acute Disease | 1 | 2026 | 1036 | 0.050 |
Why?
| | Female | 6 | 2026 | 79035 | 0.050 |
Why?
| | Adult | 2 | 2021 | 40872 | 0.040 |
Why?
| | Hair Cells, Auditory, Inner | 1 | 2001 | 16 | 0.040 |
Why?
| | Cochlea | 1 | 2001 | 73 | 0.040 |
Why?
| | Deafness | 1 | 2001 | 78 | 0.040 |
Why?
| | Gene Deletion | 1 | 2001 | 392 | 0.040 |
Why?
| | Fever | 1 | 2021 | 319 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2025 | 1751 | 0.030 |
Why?
| | Information Dissemination | 1 | 2020 | 224 | 0.030 |
Why?
| | Interprofessional Relations | 1 | 2020 | 276 | 0.030 |
Why?
| | Needs Assessment | 1 | 2020 | 403 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2024 | 883 | 0.030 |
Why?
| | Colorado | 2 | 2020 | 4556 | 0.030 |
Why?
| | Clinical Laboratory Techniques | 1 | 2018 | 96 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 2018 | 172 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2001 | 592 | 0.030 |
Why?
| | Bronchodilator Agents | 1 | 2018 | 187 | 0.030 |
Why?
| | Program Evaluation | 1 | 2020 | 944 | 0.030 |
Why?
| | Drug Prescriptions | 1 | 2018 | 288 | 0.030 |
Why?
| | Critical Care | 1 | 2021 | 702 | 0.030 |
Why?
| | Data Collection | 1 | 2018 | 643 | 0.030 |
Why?
| | Hospitals, Teaching | 1 | 2015 | 121 | 0.030 |
Why?
| | Hospitals, Urban | 1 | 2015 | 142 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2018 | 587 | 0.020 |
Why?
| | Interdisciplinary Communication | 1 | 2014 | 201 | 0.020 |
Why?
| | Recurrence | 1 | 2016 | 1139 | 0.020 |
Why?
| | Patient Care Team | 1 | 2018 | 697 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1711 | 0.020 |
Why?
| | Chronic Disease | 1 | 2015 | 1812 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2012 | 499 | 0.020 |
Why?
| | Age Factors | 1 | 2015 | 3346 | 0.020 |
Why?
| | Helix-Loop-Helix Motifs | 1 | 2001 | 12 | 0.010 |
Why?
| | Receptor, trkC | 1 | 2001 | 10 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2001 | 120 | 0.010 |
Why?
| | Histocytochemistry | 1 | 2001 | 78 | 0.010 |
Why?
| | Risk Factors | 1 | 2015 | 10917 | 0.010 |
Why?
| | Receptor, trkB | 1 | 2001 | 39 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2001 | 318 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2001 | 414 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2001 | 277 | 0.010 |
Why?
| | Evoked Potentials, Auditory | 1 | 2001 | 181 | 0.010 |
Why?
| | Cell Death | 1 | 2001 | 382 | 0.010 |
Why?
| | Neural Pathways | 1 | 2001 | 317 | 0.010 |
Why?
| | Cell Survival | 1 | 2001 | 1103 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2012 | 11793 | 0.010 |
Why?
| | Cell Movement | 1 | 2001 | 961 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2001 | 910 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2001 | 3130 | 0.010 |
Why?
| | Mice | 1 | 2001 | 18355 | 0.000 |
Why?
| | Animals | 1 | 2001 | 38097 | 0.000 |
Why?
|
|
Bakel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|